US’ Lummus & Synthomer partner on acrylic acid esters technology
“By joining forces with Synthomer, we are expanding our portfolio with a proven, high-value technology that meets growing global demand,” said Romain Lemoine, Chief Business Officer, Lummus Technology. “We will be able to deliver a comprehensive and flexible solution to our customers while leveraging Synthomer’s decades of operational excellence and product knowledge.”
Lummus Technology and Synthomer have partnered to license Synthomer’s proprietary acrylic acid esters technology.
The collaboration combines Synthomer’s expertise with Lummus’ global licensing reach, enabling flexible, high-value production using varied feedstocks, including bio-based options.
The deal expands market access and supports growing global demand.
This strategic collaboration combines Synthomer’s deep operational expertise and technological know-how in acrylic acid esters with Lummus’ global licensing capabilities and extensive customer network. Lummus will offer robust solutions to produce acrylic acid esters, a key component in several high-performance applications, with the ability to utilize variety of raw materials, including bio-based feedstocks.
“This agreement marks a significant milestone for Synthomer’s acrylate monomers business,” said Rob Tupker, President, Health & Protection and Performance Materials (HPPM) and Asia, Synthomer. “Our technology, backed by years of experience and innovation, will now reach a broader market through Lummus’ licensing platform. It’s a win-win for both companies and the industry.”
Note: The headline, insights, and image of this press release may have been refined by the ALCHEMPro staff; the rest of the content remains unchanged.
ALCHEMPro News Desk (HU)
